IDU perspectives on the design and operation of north America's first medically supervised injection facility

Substance Use and Misuse

Volumn 46, Issue 5, 2011, Pages 561-568

  Small, Will ^a,b   Ainsworth, Liz ^a   Wood, Evan ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

injection drug use; supervised injection facilities (SIFs)

Indexed keywords

ADULT; ARTICLE; CANADA; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MALE; MIDDLE AGED; NORTH AMERICA; ORGANIZATION AND MANAGEMENT; PATIENT SATISFACTION; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; STATISTICS; SUBSTANCE ABUSE;

ADULT; CANADA; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; NORTH AMERICA; PATIENT SATISFACTION; QUALITY ASSURANCE, HEALTH CARE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79952594053     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.517714     Document Type: Article

References (37)

1. Aceijas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18(5), 352-358. (Pubitemid 47374507)
2. Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination, and the health of illicit drug users. Drug & Alcohol Dependence, 88, 188-196. (Pubitemid 46482822)
3. Allman, D., Myers, T., Schellenberg, J., Strike, C., Cockerill, R., & Cavalieri, W. (2007). Improving health and social care relationships for harm reduction. International Journal of Drug Policy, 18(3), 194-203. (Pubitemid 46901015)
4. Bastos, F. I., & Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science and Medicine, 51(12), 1771-1782.
5. Broadhead, R. S., Kerr, T. H., Grund, J.-P., & Altice, F. L. (2002). Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues, 32(1), 329-355. (Pubitemid 34464915)
6. Cooper, H. F., Brady, J. E., Ciccarone, D., Tempalski, B., Gostnell, K., & Friedman, S. R. (2007). Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clinical Infectious Diseases, 45(9), 1200-1203. (Pubitemid 47580320)
7. Fairbairn, N., Small,W., Shannon, K.,Wood, E., & Kerr, T. (2008). Seeking refuge from violence in street-based drug scenes: Women's experiences in North America's first supervised injection facility. Social Science and Medicine, 67(5), 817-882.
8. Fischer, B., Turnbull, S., Poland, B., & Haydon, E. (2004). Drug use, risk and urban order: Examining supervised injection sites (SIS) as "governmentality." International Journal of Drug Policy, 15, 357-365. (Pubitemid 39488225)
9. Fry, C. L. (2002). Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. International Journal of Drug Policy, 13, 471-476. (Pubitemid 35461962)
10. Hedrich, D. (2004). European report on drug consumption rooms. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
11. Hunt, N. (2006a). An overview of models of delivery of drug consumption rooms. York, UK: Joseph Rowntree Foundation.
12. Hunt, N. (2006b). The evaluation literature on drug consumption rooms. York, UK: Joseph Rowntree Foundation.
13. Kerr, T., Fairbairn, N., Tyndall, M. W., Marsh, D., Li, K., Montaner, J., et al. (2007). Factors associated with non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug & Alcohol Dependence, 87(1), 39-45. (Pubitemid 46074383)
14. Kerr, T., Oleson, M., Tyndall, M. W., Montaner, J., & Wood, E. (2005). A description of a peer-run supervised injection site for injection drug users. Journal of Urban Health, 82(2), 267-275. (Pubitemid 41214942)
15. Kerr, T., Tyndall, M. W., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366, 316-318. (Pubitemid 41019422)
16. Kerr, T., Tyndall, M. W., Montaner, J., & Wood, E. (2004). Missed opportunities in the establishment of safer injection facilities: Reviewing the evidence to date. Paper presented at the 15th International Conference on Drug Related Harm, Melbourne, Australia.
17. Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., et al. (2004). High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health, 27(1), 62-66.
18. Kimber, J., Dolan, K., van Beek, I., Hedrich, D., & Zurhold, H. (2003). Drug consumption facilities: an update since 2000. Drug & Alcohol Review, 22, 227-233. (Pubitemid 36814874)
19. Kimber, J., Dolan, K., & Wodak, A. (2005). Survey of drug consumption rooms: Service delivery and perceived health and amenity impact. Drug and Alcohol Review, 24, 21-24. (Pubitemid 41052842)
20. Kimber, J., Hickman, M., Degenhardt, L., van Beek, I., & Coulson, T. (2005). Estimating the size of the local IDU population using client visits to the Sydney Medically Supervised Injecting Centre. Paper presented at the 16th International Conference on the Reduction of Drug Related Harm, Belfast, Northern Ireland.
21. McCoy, C. B., Metsch, L., Chitwood, D. D., & Miles, C. (2001). Drug use and barriers to use of health care services. Substance Use & Misuse, 36, 789-806. (Pubitemid 32660804)
22. MSIC Evaluation Committee. (2003). Final report of the evaluation of the Sydney medically supervised injecting centre. Sydney, Australia: Author.
23. Neale, J., Sheard, L., & Tompkins, C. (2007). Factors that help injecting drug users to access and benefit from services: A qualitative study. Substance Abuse Treatment, Prevention and Policy, 2, 31.
24. O'Connell, J. M., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J., et al. (2005). Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndrome, 40, 83-88. (Pubitemid 41233210)
25. Pearshouse, R., & Elliott, R. (2007). A helping hand: Legal issues related to assisted injection at supervised injection facilities. Toronto, ON, Canada: Canadian HIV/AIDS Legal Network.
26. Petrar, S., Kerr, T., Tyndall, M. W., Zhang, R., Montaner, J. S., & Wood, E. (2007). Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Addictive Behaviors, 32(5), 1088-1093. (Pubitemid 46282298)
27. Small, W., Rhodes, T.,Wood, E., & Kerr, T. (2007). Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy, 18, 27-36. (Pubitemid 46240799)
28. Tyndall, M. W., Craib, K. J., Currie, S., Li, K., O'Shaughnessy, M. V., & Schechter, M. T. (2001). Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndrome, 28(4), 351-357. (Pubitemid 33101288)
29. Tyndall, M.W., Kerr, T., Zhang, R.,King, E.,Montaner, J.,&Wood, E. (2006). Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug & Alcohol Dependence, 83, 193-198.
30. Warner-Smith, M., Darke, S., & Day, C. (2002). Morbidity associated with non-fatal heroin overdose. Addiction, 97(8), 963-967.
31. Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., et al. (2004).Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal, 1(1), 9.
32. Wood, E., Kerr, T., Small, W., Li, K., Marsh, D. C., Montaner, J. S., et al. (2004) Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal, 171(7), 731-734. (Pubitemid 39319089)
33. Wood, E., Tyndall, M. W., Montaner, J., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal, 175, 1399-1404. (Pubitemid 44876560)
34. Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S., et al. (2002). Factors associated with persistent highrisk syringe sharing in the presence of an established needle exchange programme. AIDS, 16(6), 941-943. (Pubitemid 34409025)
35. Wood, E., Tyndall, M. W., Stoltz, J., Small, W., Zhang, R., O'Connell, J., et al. (2005). Safer injecting education for HIV prevention in a medically supervised safer injecting facility. International Journal of Drug Policy, 16, 281-284. (Pubitemid 41558187)
36. Wood, E., Tyndall, M. W., Zhang, R., Stoltz, J., Lai, C., Montaner, J. S., et al. (2006). Attendance at supervised injecting facilities and use of detoxification services. New England Journal of Medicine, 354(23), 2512-2514. (Pubitemid 43855074)
37. Wood, E., Tyndall, M.W, Zhengou, Q., Zhang, R., Montaner, J., & Kerr, T. (2006). Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. American Journal of Public Health, 96(5), 770-773.